GSK polio vaccine to launch in July.

Published: 2006-06-02 06:59:00

Updated: 2006-06-02 06:59:00

GSK took the KFDA approval for the market release of Poliorix, an anti-poliomyelitis vaccine, which is an injectable inactivated poliovirus vaccine containing 1, 2 and 3 type of polio virus. It is administered for the baby of two month old 3 times with 4 to 8 weeks intervals via intramuscular inj...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK